High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial-Reference-Cited by-同舟云学术

High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial

Published:2016-01-21 Issue:3 Volume:127 Page:296-302
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Wei Yu¹,Ji Xue-bin¹,Wang Ya-wen¹,Wang Jing-xia²,Yang En-qin³,Wang Zheng-cheng⁴,Sang Yu-qi⁵,Bi Zuo-mu⁶,Ren Cui-ai⁷,Zhou Fang⁸,Liu Guo-qiang⁹,Peng Jun¹¹⁰,Hou Ming¹¹¹

Affiliation:

1. Department of Hematology, Qilu Hospital, Shandong University, Jinan, China;

2. Department of Hematology, Liaocheng People's Hospital, Liaocheng, China;

3. Department of Hematology, People's Hospital of Rizhao, Rizhao, China;

4. Department of Hematology, Central Hospital of Zibo, Zibo, China;

5. Department of Hematology, Heze Municipal Hospital, Heze, China;

6. Department of Hematology, Zibo First Hospital, Zibo, China;

7. Department of Hematology, Weifang People's Hospital, Weifang, China;

8. Department of Hematology, Jinan Military General Hospital, Jinan, China;

9. Department of Hematology, Shengli Oilfield General Hospital, Dongying, China;

10. Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Qilu Hospital, Shandong University, Jinan, China; and

11. Shandong Provincial Key Laboratory of Immunohematology, Qilu Hospital, Shandong University, Jinan, China

Abstract

Key Points HD-DXM is a preferred strategy to conventional prednisone as first-line management of newly diagnosed adult primary ITP.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/127/3/296/1393719/296.pdf

Reference26 articles.

1. Cellular immune dysfunction in immune thrombocytopenia (ITP).;McKenzie;Br J Haematol,2013

2. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.;Neunert;Blood,2011

3. International consensus report on the investigation and management of primary immune thrombocytopenia.;Provan;Blood,2010

4. How I treat idiopathic thrombocytopenic purpura (ITP).;Cines;Blood,2005

5. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy.;British Committee for Standards in Haematology General Haematology Task Force;Br J Haematol,2003

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of recombinant human thrombopoietin for the treatment of chronic primary immune thrombocytopenia in children and adolescents: A multicentre, randomized, double‐blind, placebo‐controlled phase III trial;British Journal of Haematology;2024-09-12

2. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice;Blood;2024-08-08

3. Rifabutin-Induced Thrombocytopenia in a Patient With Uncontrolled HIV: A Case Report;Cureus;2024-08-06

4. Cytomegalovirus-Related Immune Thrombocytopenic Purpura in an Immunocompetent Adult;Annals of Internal Medicine: Clinical Cases;2024-07-01

5. Thrombopoietin receptor agonists regulate myeloid-derived suppressor cell-mediated immunomodulatory effects in ITP;Annals of Hematology;2024-06-19